DT
CLVS

Diversified Trust’s Clovis Oncology, Inc. CLVS Stock Holding History

Diversified Trust’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-16,243
Closed -$33K – 883
2022
Q1 		$33K Hold
16,243
– – ﹤0.01% 791
2021
Q4 		$44K Hold
16,243
– – ﹤0.01% 822
2021
Q3 		$72K Hold
16,243
– – ﹤0.01% 772
2021
Q2 		$94K Hold
16,243
– – ﹤0.01% 762
2021
Q1 		$114K Sell
16,243
-1,672
-9% -$11.2K ﹤0.01% 725
2020
Q4 		$86K Buy
+17,915
New +$90.6K ﹤0.01% 713

Other funds holding CLVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
PA
Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return

Diversified Trust's CLVS Position: Q2 2022 in Review

Diversified Trust sold out of Clovis Oncology, Inc. (CLVS) in Q2 2022, closing a stake of 16,243 shares — an estimated $33K sold.

Diversified Trust first reported a position in CLVS in Q4 2020 and held it in 6 quarters. The position peaked at $114K in Q1 2021. 115 funds tracked by Wall St. Rank hold CLVS as of Q2 2022.

  • Diversified Trust reported no remaining Clovis Oncology, Inc. position as of Q2 2022 after selling out during the quarter.
  • Diversified Trust sold 16,243 Clovis Oncology, Inc. shares in Q2 2022, an estimated $33K.
  • Diversified Trust first reported a position in Clovis Oncology, Inc. in Q4 2020 and held it in 6 quarters.
  • Diversified Trust's Clovis Oncology, Inc. position peaked at $114K in Q1 2021.
  • 115 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q2 2022.

Based on Diversified Trust's 13F filing for Q2 2022, filed 12 Jul 2022.